H.R.2855: To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.

About This Bill

  • This bill was introduced in the 116th Congress
  • This bill is primarily about health
  • Introduced May 20, 2019
  • Latest Major Action May 21, 2019

Bill Sponsor

Bill Version

Bill Summary

This bill provides for approval of the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides.

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 3 statements associated with H.R.2855.

Bill Actions

Date Description
May 21, 2019
Referred to the Subcommittee on Health.
May 20, 2019
Referred to the House Committee on Energy and Commerce.
May 20, 2019

Introduced in the House by Steve King (R-Iowa)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page